Advertisement

Index by author

September 01, 1988; Volume 16,Issue 5

A

  1. Alberts, A W

    1. Metabolism of lovastatin by rat and human liver microsomes in vitro.
      M D Greenspan, J B Yudkovitz, A W Alberts, L S Argenbright, B H Arison and J L Smith
      Drug Metabolism and Disposition September 1988, 16 (5) 678-682;

  2. Anders, M W

    1. Enzymatic conjugation of hexachloro-1,3-butadiene with glutathione. Formation of 1-(glutathion-S-yl)-1,2,3,4,4-pentachlorobuta-1,3-diene and 1,4-bis(glutathion-S-yl)-1,2,3,4-tetrachlorobuta-1,3-diene.
      W Dekant, S Vamvakas, D Henschler and M W Anders
      Drug Metabolism and Disposition September 1988, 16 (5) 701-706;

  3. Argenbright, L S

    1. Metabolism of lovastatin by rat and human liver microsomes in vitro.
      M D Greenspan, J B Yudkovitz, A W Alberts, L S Argenbright, B H Arison and J L Smith
      Drug Metabolism and Disposition September 1988, 16 (5) 678-682;

  4. Arison, B H

    1. Metabolism of lovastatin by rat and human liver microsomes in vitro.
      M D Greenspan, J B Yudkovitz, A W Alberts, L S Argenbright, B H Arison and J L Smith
      Drug Metabolism and Disposition September 1988, 16 (5) 678-682;
    2. Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomes.
      K L Thompson, M N Chang, J C Chabala, S H Chiu, D Eline, H B Hucker, B M Sweeney, S D White, B H Arison and J L Smith
      Drug Metabolism and Disposition September 1988, 16 (5) 737-743;

B

  1. Baars, L G

    1. Phenylbutazone-hydroxycoumarol interactions. Effects on steady state disposition, hepatocellular distribution, and biliary excretion of (S)-acenocoumarol in rats.
      H H Thijssen, L G Baars and G M Janssen
      Drug Metabolism and Disposition September 1988, 16 (5) 744-748;

  2. Beedle, E

    1. Metabolism of the prodrug DEGA (N-(2,6-dimethylphenyl)-4-[[(diethylamino)acetyl]amino]benzamide) to the potent anticonvulsant LY201116 in mice. Effect of bis-(p-nitrophenyl)phosphate.
      C J Parli, E Evenson, B D Potts, E Beedle, R Lawson, D W Robertson and J D Leander
      Drug Metabolism and Disposition September 1988, 16 (5) 707-711;

  3. Birnbaum, L S

    1. Disposition of citral in male Fischer rats.
      J J Diliberto, G Usha and L S Birnbaum
      Drug Metabolism and Disposition September 1988, 16 (5) 721-727;

  4. Bonati, M

    1. Cyclosporine pharmacokinetics in rats and interspecies comparison in dogs, rabbits, rats, and humans.
      L Sangalli, A Bortolotti, L Jiritano and M Bonati
      Drug Metabolism and Disposition September 1988, 16 (5) 749-753;

  5. Bortolotti, A

    1. Cyclosporine pharmacokinetics in rats and interspecies comparison in dogs, rabbits, rats, and humans.
      L Sangalli, A Bortolotti, L Jiritano and M Bonati
      Drug Metabolism and Disposition September 1988, 16 (5) 749-753;

  6. Burk, R F

    1. Metabolism of ethane and pentane to carbon dioxide by the rat.
      M S Daugherty, T M Ludden and R F Burk
      Drug Metabolism and Disposition September 1988, 16 (5) 666-671;

C

  1. Carlin, J R

    1. Comparative metabolic disposition of ivermectin in fat tissues of cattle, sheep, and rats.
      S H Chiu, J R Carlin, R Taub, E Sestokas, J Zweig, W J Vandenheuvel and T A Jacob
      Drug Metabolism and Disposition September 1988, 16 (5) 728-736;

  2. Chabala, J C

    1. Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomes.
      K L Thompson, M N Chang, J C Chabala, S H Chiu, D Eline, H B Hucker, B M Sweeney, S D White, B H Arison and J L Smith
      Drug Metabolism and Disposition September 1988, 16 (5) 737-743;

  3. Chang, M N

    1. Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomes.
      K L Thompson, M N Chang, J C Chabala, S H Chiu, D Eline, H B Hucker, B M Sweeney, S D White, B H Arison and J L Smith
      Drug Metabolism and Disposition September 1988, 16 (5) 737-743;

  4. Chiu, S H

    1. Comparative metabolic disposition of ivermectin in fat tissues of cattle, sheep, and rats.
      S H Chiu, J R Carlin, R Taub, E Sestokas, J Zweig, W J Vandenheuvel and T A Jacob
      Drug Metabolism and Disposition September 1988, 16 (5) 728-736;
    2. Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomes.
      K L Thompson, M N Chang, J C Chabala, S H Chiu, D Eline, H B Hucker, B M Sweeney, S D White, B H Arison and J L Smith
      Drug Metabolism and Disposition September 1988, 16 (5) 737-743;

D

  1. D'Souza, M J

    1. Pharmacokinetics of cyclosporine in streptozotocin-induced diabetic rats.
      M J D'Souza, H M Solomon, L C Fowler and S H Pollock
      Drug Metabolism and Disposition September 1988, 16 (5) 778-780;

  2. Daugherty, M S

    1. Metabolism of ethane and pentane to carbon dioxide by the rat.
      M S Daugherty, T M Ludden and R F Burk
      Drug Metabolism and Disposition September 1988, 16 (5) 666-671;

  3. Dekant, W

    1. Enzymatic conjugation of hexachloro-1,3-butadiene with glutathione. Formation of 1-(glutathion-S-yl)-1,2,3,4,4-pentachlorobuta-1,3-diene and 1,4-bis(glutathion-S-yl)-1,2,3,4-tetrachlorobuta-1,3-diene.
      W Dekant, S Vamvakas, D Henschler and M W Anders
      Drug Metabolism and Disposition September 1988, 16 (5) 701-706;

  4. deLuna, F A

    1. Disposition and metabolism of sodium 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-gamma -oxobenzenebutanoate in rats and dogs.
      D J Tocco, F A deLuna, A E Duncan, H G Ramjit, S M Pitzenberger and J Y Hsieh
      Drug Metabolism and Disposition September 1988, 16 (5) 690-696;
    2. The physiological disposition of aerosolized 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-gamma -oxobenzenebutanoate (L-648,051) in rats.
      D J Tocco, A E Duncan, F A deLuna and G Wells
      Drug Metabolism and Disposition September 1988, 16 (5) 697-700;

  5. Diliberto, J J

    1. Disposition of citral in male Fischer rats.
      J J Diliberto, G Usha and L S Birnbaum
      Drug Metabolism and Disposition September 1988, 16 (5) 721-727;

  6. Duncan, A E

    1. Disposition and metabolism of sodium 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-gamma -oxobenzenebutanoate in rats and dogs.
      D J Tocco, F A deLuna, A E Duncan, H G Ramjit, S M Pitzenberger and J Y Hsieh
      Drug Metabolism and Disposition September 1988, 16 (5) 690-696;
    2. The physiological disposition of aerosolized 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-gamma -oxobenzenebutanoate (L-648,051) in rats.
      D J Tocco, A E Duncan, F A deLuna and G Wells
      Drug Metabolism and Disposition September 1988, 16 (5) 697-700;

E

  1. Eline, D

    1. Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomes.
      K L Thompson, M N Chang, J C Chabala, S H Chiu, D Eline, H B Hucker, B M Sweeney, S D White, B H Arison and J L Smith
      Drug Metabolism and Disposition September 1988, 16 (5) 737-743;

  2. Endo, H

    1. Comparative study on the disposition of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine hydrochloride in rats and dogs.
      M Yoshikawa, H Endo, M Otsuka, I Yamaguchi and S Harigaya
      Drug Metabolism and Disposition September 1988, 16 (5) 754-758;

  3. Evenson, E

    1. Metabolism of the prodrug DEGA (N-(2,6-dimethylphenyl)-4-[[(diethylamino)acetyl]amino]benzamide) to the potent anticonvulsant LY201116 in mice. Effect of bis-(p-nitrophenyl)phosphate.
      C J Parli, E Evenson, B D Potts, E Beedle, R Lawson, D W Robertson and J D Leander
      Drug Metabolism and Disposition September 1988, 16 (5) 707-711;

F

  1. Fowler, L C

    1. Pharmacokinetics of cyclosporine in streptozotocin-induced diabetic rats.
      M J D'Souza, H M Solomon, L C Fowler and S H Pollock
      Drug Metabolism and Disposition September 1988, 16 (5) 778-780;

  2. Fukuda, E K

    1. Urinary metabolites of rimantadine in humans.
      F R Rubio, E K Fukuda and W A Garland
      Drug Metabolism and Disposition September 1988, 16 (5) 773-777;

G

  1. Garland, W A

    1. Urinary metabolites of rimantadine in humans.
      F R Rubio, E K Fukuda and W A Garland
      Drug Metabolism and Disposition September 1988, 16 (5) 773-777;

  2. Girault, J P

    1. Ecdysone catabolism in the white mouse.
      J P Girault, R Lafont and U Kerb
      Drug Metabolism and Disposition September 1988, 16 (5) 716-720;

  3. Greenspan, M D

    1. Metabolism of lovastatin by rat and human liver microsomes in vitro.
      M D Greenspan, J B Yudkovitz, A W Alberts, L S Argenbright, B H Arison and J L Smith
      Drug Metabolism and Disposition September 1988, 16 (5) 678-682;

H

  1. Harigaya, S

    1. Comparative study on the disposition of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine hydrochloride in rats and dogs.
      M Yoshikawa, H Endo, M Otsuka, I Yamaguchi and S Harigaya
      Drug Metabolism and Disposition September 1988, 16 (5) 754-758;

  2. Heath, J E

    1. The disposition and toxicology of retinyl methyl ether in rats dosed orally.
      D M McPhillips, C Lindamood, J E Heath and D L Hill
      Drug Metabolism and Disposition September 1988, 16 (5) 683-689;

  3. Henschler, D

    1. Enzymatic conjugation of hexachloro-1,3-butadiene with glutathione. Formation of 1-(glutathion-S-yl)-1,2,3,4,4-pentachlorobuta-1,3-diene and 1,4-bis(glutathion-S-yl)-1,2,3,4-tetrachlorobuta-1,3-diene.
      W Dekant, S Vamvakas, D Henschler and M W Anders
      Drug Metabolism and Disposition September 1988, 16 (5) 701-706;

  4. Hill, D L

    1. The disposition and toxicology of retinyl methyl ether in rats dosed orally.
      D M McPhillips, C Lindamood, J E Heath and D L Hill
      Drug Metabolism and Disposition September 1988, 16 (5) 683-689;

  5. Hsieh, J Y

    1. Disposition and metabolism of sodium 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-gamma -oxobenzenebutanoate in rats and dogs.
      D J Tocco, F A deLuna, A E Duncan, H G Ramjit, S M Pitzenberger and J Y Hsieh
      Drug Metabolism and Disposition September 1988, 16 (5) 690-696;

  6. Hucker, H B

    1. Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomes.
      K L Thompson, M N Chang, J C Chabala, S H Chiu, D Eline, H B Hucker, B M Sweeney, S D White, B H Arison and J L Smith
      Drug Metabolism and Disposition September 1988, 16 (5) 737-743;

J

  1. Jacob, T A

    1. Comparative metabolic disposition of ivermectin in fat tissues of cattle, sheep, and rats.
      S H Chiu, J R Carlin, R Taub, E Sestokas, J Zweig, W J Vandenheuvel and T A Jacob
      Drug Metabolism and Disposition September 1988, 16 (5) 728-736;

  2. James, R C

    1. Comparison of human and mouse liver microsomal metabolism of bromobenzene and chlorobenzene to 2- and 4-halophenols.
      B D Kerger, S M Roberts and R C James
      Drug Metabolism and Disposition September 1988, 16 (5) 672-677;

  3. Janssen, G M

    1. Phenylbutazone-hydroxycoumarol interactions. Effects on steady state disposition, hepatocellular distribution, and biliary excretion of (S)-acenocoumarol in rats.
      H H Thijssen, L G Baars and G M Janssen
      Drug Metabolism and Disposition September 1988, 16 (5) 744-748;

  4. Jiritano, L

    1. Cyclosporine pharmacokinetics in rats and interspecies comparison in dogs, rabbits, rats, and humans.
      L Sangalli, A Bortolotti, L Jiritano and M Bonati
      Drug Metabolism and Disposition September 1988, 16 (5) 749-753;

K

  1. Kerb, U

    1. Ecdysone catabolism in the white mouse.
      J P Girault, R Lafont and U Kerb
      Drug Metabolism and Disposition September 1988, 16 (5) 716-720;

  2. Kerger, B D

    1. Comparison of human and mouse liver microsomal metabolism of bromobenzene and chlorobenzene to 2- and 4-halophenols.
      B D Kerger, S M Roberts and R C James
      Drug Metabolism and Disposition September 1988, 16 (5) 672-677;

L

  1. Lafont, R

    1. Ecdysone catabolism in the white mouse.
      J P Girault, R Lafont and U Kerb
      Drug Metabolism and Disposition September 1988, 16 (5) 716-720;

  2. Lawson, R

    1. Metabolism of the prodrug DEGA (N-(2,6-dimethylphenyl)-4-[[(diethylamino)acetyl]amino]benzamide) to the potent anticonvulsant LY201116 in mice. Effect of bis-(p-nitrophenyl)phosphate.
      C J Parli, E Evenson, B D Potts, E Beedle, R Lawson, D W Robertson and J D Leander
      Drug Metabolism and Disposition September 1988, 16 (5) 707-711;

  3. Leander, J D

    1. Metabolism of the prodrug DEGA (N-(2,6-dimethylphenyl)-4-[[(diethylamino)acetyl]amino]benzamide) to the potent anticonvulsant LY201116 in mice. Effect of bis-(p-nitrophenyl)phosphate.
      C J Parli, E Evenson, B D Potts, E Beedle, R Lawson, D W Robertson and J D Leander
      Drug Metabolism and Disposition September 1988, 16 (5) 707-711;

  4. Lee, R F

    1. Induction of monooxygenase activity in the intestine of spot (Leiostomus xanthurus), a marine teleost, by dietary polycyclic aromatic hydrocarbons.
      P A van Veld, J J Stegeman, B R Woodin, J S Patton and R F Lee
      Drug Metabolism and Disposition September 1988, 16 (5) 659-665;

  5. Lindamood, C

    1. The disposition and toxicology of retinyl methyl ether in rats dosed orally.
      D M McPhillips, C Lindamood, J E Heath and D L Hill
      Drug Metabolism and Disposition September 1988, 16 (5) 683-689;

  6. Ludden, T M

    1. Metabolism of ethane and pentane to carbon dioxide by the rat.
      M S Daugherty, T M Ludden and R F Burk
      Drug Metabolism and Disposition September 1988, 16 (5) 666-671;

M

  1. Madyastha, K M

    1. Studies on the metabolism of l-menthol in rats.
      K M Madyastha and V Srivatsan
      Drug Metabolism and Disposition September 1988, 16 (5) 765-772;

  2. McPhillips, D M

    1. The disposition and toxicology of retinyl methyl ether in rats dosed orally.
      D M McPhillips, C Lindamood, J E Heath and D L Hill
      Drug Metabolism and Disposition September 1988, 16 (5) 683-689;

O

  1. Otsuka, M

    1. Comparative study on the disposition of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine hydrochloride in rats and dogs.
      M Yoshikawa, H Endo, M Otsuka, I Yamaguchi and S Harigaya
      Drug Metabolism and Disposition September 1988, 16 (5) 754-758;

P

  1. Parli, C J

    1. Metabolism of the prodrug DEGA (N-(2,6-dimethylphenyl)-4-[[(diethylamino)acetyl]amino]benzamide) to the potent anticonvulsant LY201116 in mice. Effect of bis-(p-nitrophenyl)phosphate.
      C J Parli, E Evenson, B D Potts, E Beedle, R Lawson, D W Robertson and J D Leander
      Drug Metabolism and Disposition September 1988, 16 (5) 707-711;

  2. Patton, J S

    1. Induction of monooxygenase activity in the intestine of spot (Leiostomus xanthurus), a marine teleost, by dietary polycyclic aromatic hydrocarbons.
      P A van Veld, J J Stegeman, B R Woodin, J S Patton and R F Lee
      Drug Metabolism and Disposition September 1988, 16 (5) 659-665;

  3. Pitzenberger, S M

    1. Disposition and metabolism of sodium 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-gamma -oxobenzenebutanoate in rats and dogs.
      D J Tocco, F A deLuna, A E Duncan, H G Ramjit, S M Pitzenberger and J Y Hsieh
      Drug Metabolism and Disposition September 1988, 16 (5) 690-696;

  4. Pollock, S H

    1. Pharmacokinetics of cyclosporine in streptozotocin-induced diabetic rats.
      M J D'Souza, H M Solomon, L C Fowler and S H Pollock
      Drug Metabolism and Disposition September 1988, 16 (5) 778-780;

  5. Potts, B D

    1. Metabolism of the prodrug DEGA (N-(2,6-dimethylphenyl)-4-[[(diethylamino)acetyl]amino]benzamide) to the potent anticonvulsant LY201116 in mice. Effect of bis-(p-nitrophenyl)phosphate.
      C J Parli, E Evenson, B D Potts, E Beedle, R Lawson, D W Robertson and J D Leander
      Drug Metabolism and Disposition September 1988, 16 (5) 707-711;

R

  1. Ramjit, H G

    1. Disposition and metabolism of sodium 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-gamma -oxobenzenebutanoate in rats and dogs.
      D J Tocco, F A deLuna, A E Duncan, H G Ramjit, S M Pitzenberger and J Y Hsieh
      Drug Metabolism and Disposition September 1988, 16 (5) 690-696;

  2. Reinke, L A

    1. Sulfation of acetaminophen in isolated rat hepatocytes. Relationship to sulfate ion concentrations and intracellular levels of 3'-phosphoadenosine-5'-phosphosulfate.
      D J Sweeny and L A Reinke
      Drug Metabolism and Disposition September 1988, 16 (5) 712-715;

  3. Roberts, S M

    1. Comparison of human and mouse liver microsomal metabolism of bromobenzene and chlorobenzene to 2- and 4-halophenols.
      B D Kerger, S M Roberts and R C James
      Drug Metabolism and Disposition September 1988, 16 (5) 672-677;

  4. Robertson, D W

    1. Metabolism of the prodrug DEGA (N-(2,6-dimethylphenyl)-4-[[(diethylamino)acetyl]amino]benzamide) to the potent anticonvulsant LY201116 in mice. Effect of bis-(p-nitrophenyl)phosphate.
      C J Parli, E Evenson, B D Potts, E Beedle, R Lawson, D W Robertson and J D Leander
      Drug Metabolism and Disposition September 1988, 16 (5) 707-711;

  5. Rubio, F R

    1. Urinary metabolites of rimantadine in humans.
      F R Rubio, E K Fukuda and W A Garland
      Drug Metabolism and Disposition September 1988, 16 (5) 773-777;

S

  1. Sangalli, L

    1. Cyclosporine pharmacokinetics in rats and interspecies comparison in dogs, rabbits, rats, and humans.
      L Sangalli, A Bortolotti, L Jiritano and M Bonati
      Drug Metabolism and Disposition September 1988, 16 (5) 749-753;

  2. Sestokas, E

    1. Comparative metabolic disposition of ivermectin in fat tissues of cattle, sheep, and rats.
      S H Chiu, J R Carlin, R Taub, E Sestokas, J Zweig, W J Vandenheuvel and T A Jacob
      Drug Metabolism and Disposition September 1988, 16 (5) 728-736;

  3. Smith, J L

    1. Metabolism of lovastatin by rat and human liver microsomes in vitro.
      M D Greenspan, J B Yudkovitz, A W Alberts, L S Argenbright, B H Arison and J L Smith
      Drug Metabolism and Disposition September 1988, 16 (5) 678-682;
    2. Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomes.
      K L Thompson, M N Chang, J C Chabala, S H Chiu, D Eline, H B Hucker, B M Sweeney, S D White, B H Arison and J L Smith
      Drug Metabolism and Disposition September 1988, 16 (5) 737-743;

  4. Solomon, H M

    1. Pharmacokinetics of cyclosporine in streptozotocin-induced diabetic rats.
      M J D'Souza, H M Solomon, L C Fowler and S H Pollock
      Drug Metabolism and Disposition September 1988, 16 (5) 778-780;

  5. Srivatsan, V

    1. Studies on the metabolism of l-menthol in rats.
      K M Madyastha and V Srivatsan
      Drug Metabolism and Disposition September 1988, 16 (5) 765-772;

  6. Stegeman, J J

    1. Induction of monooxygenase activity in the intestine of spot (Leiostomus xanthurus), a marine teleost, by dietary polycyclic aromatic hydrocarbons.
      P A van Veld, J J Stegeman, B R Woodin, J S Patton and R F Lee
      Drug Metabolism and Disposition September 1988, 16 (5) 659-665;

  7. Svensson, L A

    1. Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.
      A Tunek and L A Svensson
      Drug Metabolism and Disposition September 1988, 16 (5) 759-764;

  8. Sweeney, B M

    1. Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomes.
      K L Thompson, M N Chang, J C Chabala, S H Chiu, D Eline, H B Hucker, B M Sweeney, S D White, B H Arison and J L Smith
      Drug Metabolism and Disposition September 1988, 16 (5) 737-743;

  9. Sweeny, D J

    1. Sulfation of acetaminophen in isolated rat hepatocytes. Relationship to sulfate ion concentrations and intracellular levels of 3'-phosphoadenosine-5'-phosphosulfate.
      D J Sweeny and L A Reinke
      Drug Metabolism and Disposition September 1988, 16 (5) 712-715;

T

  1. Taub, R

    1. Comparative metabolic disposition of ivermectin in fat tissues of cattle, sheep, and rats.
      S H Chiu, J R Carlin, R Taub, E Sestokas, J Zweig, W J Vandenheuvel and T A Jacob
      Drug Metabolism and Disposition September 1988, 16 (5) 728-736;

  2. Thijssen, H H

    1. Phenylbutazone-hydroxycoumarol interactions. Effects on steady state disposition, hepatocellular distribution, and biliary excretion of (S)-acenocoumarol in rats.
      H H Thijssen, L G Baars and G M Janssen
      Drug Metabolism and Disposition September 1988, 16 (5) 744-748;

  3. Thompson, K L

    1. Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomes.
      K L Thompson, M N Chang, J C Chabala, S H Chiu, D Eline, H B Hucker, B M Sweeney, S D White, B H Arison and J L Smith
      Drug Metabolism and Disposition September 1988, 16 (5) 737-743;

  4. Tocco, D J

    1. Disposition and metabolism of sodium 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-gamma -oxobenzenebutanoate in rats and dogs.
      D J Tocco, F A deLuna, A E Duncan, H G Ramjit, S M Pitzenberger and J Y Hsieh
      Drug Metabolism and Disposition September 1988, 16 (5) 690-696;
    2. The physiological disposition of aerosolized 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-gamma -oxobenzenebutanoate (L-648,051) in rats.
      D J Tocco, A E Duncan, F A deLuna and G Wells
      Drug Metabolism and Disposition September 1988, 16 (5) 697-700;

  5. Tunek, A

    1. Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.
      A Tunek and L A Svensson
      Drug Metabolism and Disposition September 1988, 16 (5) 759-764;

U

  1. Usha, G

    1. Disposition of citral in male Fischer rats.
      J J Diliberto, G Usha and L S Birnbaum
      Drug Metabolism and Disposition September 1988, 16 (5) 721-727;

V

  1. Vamvakas, S

    1. Enzymatic conjugation of hexachloro-1,3-butadiene with glutathione. Formation of 1-(glutathion-S-yl)-1,2,3,4,4-pentachlorobuta-1,3-diene and 1,4-bis(glutathion-S-yl)-1,2,3,4-tetrachlorobuta-1,3-diene.
      W Dekant, S Vamvakas, D Henschler and M W Anders
      Drug Metabolism and Disposition September 1988, 16 (5) 701-706;

  2. Vandenheuvel, W J

    1. Comparative metabolic disposition of ivermectin in fat tissues of cattle, sheep, and rats.
      S H Chiu, J R Carlin, R Taub, E Sestokas, J Zweig, W J Vandenheuvel and T A Jacob
      Drug Metabolism and Disposition September 1988, 16 (5) 728-736;

  3. van Veld, P A

    1. Induction of monooxygenase activity in the intestine of spot (Leiostomus xanthurus), a marine teleost, by dietary polycyclic aromatic hydrocarbons.
      P A van Veld, J J Stegeman, B R Woodin, J S Patton and R F Lee
      Drug Metabolism and Disposition September 1988, 16 (5) 659-665;

W

  1. Wells, G

    1. The physiological disposition of aerosolized 4-[(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl)sulfonyl]-gamma -oxobenzenebutanoate (L-648,051) in rats.
      D J Tocco, A E Duncan, F A deLuna and G Wells
      Drug Metabolism and Disposition September 1988, 16 (5) 697-700;

  2. White, S D

    1. Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomes.
      K L Thompson, M N Chang, J C Chabala, S H Chiu, D Eline, H B Hucker, B M Sweeney, S D White, B H Arison and J L Smith
      Drug Metabolism and Disposition September 1988, 16 (5) 737-743;

  3. Woodin, B R

    1. Induction of monooxygenase activity in the intestine of spot (Leiostomus xanthurus), a marine teleost, by dietary polycyclic aromatic hydrocarbons.
      P A van Veld, J J Stegeman, B R Woodin, J S Patton and R F Lee
      Drug Metabolism and Disposition September 1988, 16 (5) 659-665;

Y

  1. Yamaguchi, I

    1. Comparative study on the disposition of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine hydrochloride in rats and dogs.
      M Yoshikawa, H Endo, M Otsuka, I Yamaguchi and S Harigaya
      Drug Metabolism and Disposition September 1988, 16 (5) 754-758;

  2. Yoshikawa, M

    1. Comparative study on the disposition of a new orally active dopamine prodrug, N-(N-acetyl-L-methionyl)-O,O-bis(ethoxycarbonyl)dopamine (TA-870) and dopamine hydrochloride in rats and dogs.
      M Yoshikawa, H Endo, M Otsuka, I Yamaguchi and S Harigaya
      Drug Metabolism and Disposition September 1988, 16 (5) 754-758;

  3. Yudkovitz, J B

    1. Metabolism of lovastatin by rat and human liver microsomes in vitro.
      M D Greenspan, J B Yudkovitz, A W Alberts, L S Argenbright, B H Arison and J L Smith
      Drug Metabolism and Disposition September 1988, 16 (5) 678-682;

Z

  1. Zweig, J

    1. Comparative metabolic disposition of ivermectin in fat tissues of cattle, sheep, and rats.
      S H Chiu, J R Carlin, R Taub, E Sestokas, J Zweig, W J Vandenheuvel and T A Jacob
      Drug Metabolism and Disposition September 1988, 16 (5) 728-736;
Back to top

In this issue